All News

The program will include branded obesity glucagon-like peptide-1 medications, which will have a transparent monthly cost.

Topline results from a phase 3 trial showed 64.1% of patients on atogepant achieved a 50% or greater reduction in mean monthly migraine days during months 4 to 6.

Independent pharmacy owner and educator Amina Abubakar, PharmD, AAHIVP, shares her hopes for the future of the pharmacy industry and advice for the next generation of pharmacists.

Real-world effectiveness data showed semaglutide reduced the risk of major kidney disease events by 26%.

Investigators also found that a change in brain functional network connectivity could also be associated with type 2 diabetes risk.

Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.

PP405 targets the primary biological pathway that controls the natural hair growth cycle, separating it from existing therapies.

Researchers conducted a review that provided updated evidence regarding the pneumococcal disease burden, the evolution of pneumococcal vaccines, and the latest immunization strategies.

A conversation with Taylor Watterson, PharmD, PhD, assistant professor at the University of Chicago Illinois Retzky College of Pharmacy.

Researchers wanted to address the potential impact of pharmacist-led influenza immunization services on vaccine uptake in older adults living in Denmark.

Amina Abubakar, PharmD, AAHIVP, joined Drug Topics to discuss her career journey as an independent pharmacy owner and the ways in which she’s been able to grow her business.

Providers can prescribe the 12.5 mg and 15 mg vials of tirzepatide starting July 7, with shipments beginning in early August.

Researchers investigated Norwegian pharmacists to understand their expertise, and potential knowledge gaps, regarding issues of epilepsy and treatment using antiseizure medication.

This study is the first to compare 2 biologics for patients with chronic rhinosinusitis with nasal polyps and coexisting asthma.

In 2023, drug overdose deaths sustained declines, but there are still disparities that need to be addressed to continue to decrease these numbers.

At the Total Pharmacy Solutions Summit Spring 2025 event, diagnostics experts Jenna Anderson and Amanda Wiley explored community pharmacists’ role in at-home testing.

The future of pharmacy services is not just about dispensing medications but about providing comprehensive and accessible clinical care that meets evolving patient needs.

Patients who received pharmacist support reached their A1c goal 14 months sooner than those who did not receive the care.

Researchers developed, pilot-tested, and evaluated the feasibility of a telehealth electronic application that simulated pharmacists’ prescribing of contraceptives to adolescents and young adults.

Polypharmacy and potentially inappropriate medications are cited as concerns in older adults who require long-term care, especially for those with comorbidities or at multiple institutions.

Researchers conducted a systematic review to summarize research that has addressed social media’s impact on skin health promotion activities.

For women in rural populations, access to education and care is limited, causing disparities in diabetes care.

At the Total Pharmacy Solutions Summit Spring 2025, Ashley Keller, CPhT, discussed innovative ways to make pharmacy businesses thrive and, in turn, benefit patients.

The therapy is the first and only oral direct acting antiviral approved by the FDA for HCV infection.

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.

Investigators find that patients with moderate weight loss or those who were weight resistant still had improvement in cardiometabolic health.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

Investigators find that the risk for new-onset diabetes is especially prominent for patients aged 20 to 29 years.